Medidata Wins Informa CARE Award for “Clinical Trial Partnership of the Year”

NEW YORK–(BUSINESS WIRE)– Medidata
(NASDAQ:MDSO), the leading global provider of cloud-based technology and
data analytics for clinical research, is pleased to announce that its
unique technology collaboration with TESARO,
Inc. was recognized as the 2017 “Clinical Partnership of the Year”
at the second annual Clinical and Research Excellence (CARE) Awards.

An oncology-focused biopharmaceutical company and Medidata customer
since 2013, TESARO worked closely with Medidata to provide feedback on
new features to Medidata
Balance^®, a powerful randomization and trial supply
management (RTSM) tool that is an integral part of the Medidata
Clinical Cloud^®. The software’s newest functionality
enables users to pool clinical supply inventory across multiple trials
at the same research site—decreasing costs, shortening timelines, and,
ultimately, leading to better treatments for patients sooner.

Hosted by Informa’s Pharma Intelligence—the world’s leading provider of
clinical and research intelligence and analysis, and home of leading
brands such as Scrip Intelligence, In Vivo and the Pink Sheet—the CARE
Awards celebrate excellence and innovation in the global life sciences
industry and a continued commitment to improving health worldwide. A
panel of esteemed judges, comprised of independent, senior industry
experts from around the world, presented the top honor to Medidata and
TESARO at the April 5 awards ceremony in Boston.

The CARE Awards judges said: “Together, Medidata and TESARO pioneered a
cross-functional product development process and worked closely on the
software blueprints to build Medidata Balance. This tool allows sponsors
the ability to pool drug supply in trials, decrease cost on drug
labeling, packaging, and shipping by sharing inventory across multiple
trials. This project was a win-win for both companies, and the product
has the potential to be adopted by many more organizations.”

The industry’s only fully configurable RTSM solution, Balance is unified
with Medidata’s industry-leading electronic data capture (EDC),
management and reporting system, Medidata
Rave^®. The combined solution reduces data reconciliation
costs between EDC and IVRS/IWRS, and decreases data entry time by 35%.
Now, with its site-pooling feature, Balance is providing even further
value to its customers by increasing drug utilization efficiencies and
streamlining drug assignment to save money, reduce waste and minimize
supply outage. TESARO recently estimated 39% less package waste and a
34% reduction in shipping costs via the site level pooling feature.

Mike Capone, Medidata’s chief operating officer, said: « At a time when
clinical R&D costs are climbing, the need for strong collaboration
between key industry stakeholders has never been more paramount.
Medidata is passionate about partnering with our customers to understand
the unique challenges hindering their clinical research programs, and
subsequently building novel solutions to alleviate those pain points and
advance their scientific goals. Our work with TESARO is a shining
example of the power of bringing together technological, operational and
therapeutic expertise, and we are honored to accept this joint award. »

Connect with Medidata

• Read our blog, Geeks
  Talk Clinical
• Tweet this:.
  .@Medidata & @TESAROBIO win @Pharma_Intell’s #Clinical Partnership of
  the Year award for #tech innovation! #CARE2017 http://ow.ly/PfRc30aDRqq
• Follow us on Twitter: @Medidata
• Find us on LinkedIn

About Medidata

Medidata
is reinventing global drug and medical device development by creating
the industry’s leading cloud-based solutions for clinical research.
Through our advanced applications and intelligent data analytics,
Medidata helps advance the scientific goals of life sciences customers
worldwide, including nearly 800 global pharmaceutical companies,
innovative biotech, diagnostic and device firms, leading academic
medical centers, and contract research organizations.

The Medidata Clinical Cloud^® brings a new level of quality
and efficiency to clinical trials that empower our customers to make
more informed decisions earlier and faster. Our unparalleled clinical
trial data assets provide deep insights that pave the way for future
growth. The Medidata Clinical Cloud is the primary technology solution
powering clinical trials for 17 of the world’s top 25 global
pharmaceutical companies and is used by 16 of the top 20 medical device
developers—from study design and planning through execution, management
and reporting.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170406006364/en/